151 related articles for article (PubMed ID: 37636465)
21. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
[TBL] [Abstract][Full Text] [Related]
22. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
23. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
[TBL] [Abstract][Full Text] [Related]
24. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.
Zhao Y; Hu K; Zhang J; Guo Y; Fan X; Wang Y; Mensah SD; Zhang X
BMC Infect Dis; 2019 May; 19(1):452. PubMed ID: 31113374
[TBL] [Abstract][Full Text] [Related]
25. Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Volakli E; Karyoti A; Sdougka M; Tsakris A; Roilides E
Microb Drug Resist; 2019 Nov; 25(9):1347-1356. PubMed ID: 31364923
[TBL] [Abstract][Full Text] [Related]
26. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
28. Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos U; Silva-Sánchez J; López-Jácome LE; Hernández-Durán M; Colín-Castro CA; Sánchez-Pérez A; Rodríguez-Santiago J; Morfín-Otero R; Rodriguez-Noriega E; Velázquez-Acosta MD; Vázquez-Larios MDR; Feliciano-Guzmán JM; Rojas-Larios F; Ponce-De-Leon A; Lozano-Garcia M; Choy-Chang EV; López-Gutiérrez E; Molina-Jaimes A; Gil-Veloz M; Corte-Rojas RE; López-Ovilla I; Ramirez-Mis JL; Rodríguez-Balderas DE; Molina-Chavarria A; Padilla-Ibarra C; Quevedo-Ramos MA; Mireles-Dávalos CD; Rodríguez-Medina N; Rubio-Mendoza D; Córdova-Fletes C; Cruz-López F; Becerra-Montejano DA; Mercado-Longoria R; Martínez-Villarreal RT; Barlandas-Rendón NRE; Mena-Ramírez JP; Couoh-May CA; Alcaraz-Espejel M; Adame-Alvarez C; Hernández-Vicente L; Garza-González E
Microb Drug Resist; 2023 Jun; 29(6):239-248. PubMed ID: 36595348
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and molecular characterization of carbapenemase-producing gram-negative bacteria from a university hospital in China.
Sun Y; Li M; Chen L; Chen H; Yu X; Ye J; Zhang Y; Ma C; Zhou T
Infect Dis (Lond); 2016 Feb; 48(2):138-46. PubMed ID: 26463362
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and mortality outcome of carbapenem- and colistin-resistant
Balkhair A; Saadi KA; Adawi BA
IJID Reg; 2023 Jun; 7():1-5. PubMed ID: 36936715
[TBL] [Abstract][Full Text] [Related]
31. Targeted surveillance of nosocomial infection in intensive care units of 176 hospitals in Jiangsu province, China.
Li Y; Cao X; Ge H; Jiang Y; Zhou H; Zheng W
J Hosp Infect; 2018 May; 99(1):36-41. PubMed ID: 29051092
[TBL] [Abstract][Full Text] [Related]
32. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
[TBL] [Abstract][Full Text] [Related]
33. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
34. The Simplified Carbapenem Inactivation Method (sCIM) for Simple and Accurate Detection of Carbapenemase-Producing Gram-Negative Bacilli.
Jing X; Zhou H; Min X; Zhang X; Yang Q; Du S; Li Y; Yu F; Jia M; Zhan Y; Zeng Y; Yang B; Pan Y; Lu B; Liu R; Zeng J
Front Microbiol; 2018; 9():2391. PubMed ID: 30425686
[TBL] [Abstract][Full Text] [Related]
35. Investigation of Extended-Spectrum β-Lactamase and Carbapenemase Producing Gram-Negative Bacilli in Rectal Swabs Collected from Neonates and Their Associated Factors in Neonatal Intensive Care Units of Southern Ethiopia.
Zakir A; Regasa Dadi B; Aklilu A; Oumer Y
Infect Drug Resist; 2021; 14():3907-3917. PubMed ID: 34588786
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital.
Chen Y; Ai L; Guo P; Huang H; Wu Z; Liang X; Liao K
BMC Infect Dis; 2018 Dec; 18(1):614. PubMed ID: 30509192
[TBL] [Abstract][Full Text] [Related]
37. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.
Ogutlu A; Guclu E; Karabay O; Utku AC; Tuna N; Yahyaoglu M
Ann Clin Microbiol Antimicrob; 2014 Jan; 13():7. PubMed ID: 24405720
[TBL] [Abstract][Full Text] [Related]
38. Active screening and patient-placement and cohort-placement strategies to decrease carbapenem-resistant gram-negative bacilli colonization and infection in pediatric patients: A 5-year retrospective observational study in China.
Yin LJ; He LY; Lu GP; Cao Y; Wang LS; Zhai XW; Wang CQ
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1666-1669. PubMed ID: 37088554
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
[TBL] [Abstract][Full Text] [Related]
40. A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes.
Manandhar S; Zellweger RM; Maharjan N; Dongol S; Prajapati KG; Thwaites G; Basnyat B; Dixit SM; Baker S; Karkey A
Ann Clin Microbiol Antimicrob; 2020 Oct; 19(1):48. PubMed ID: 33087115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
